GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Elos Medtech AB (CHIX:ELOSBs) » Definitions » Cyclically Adjusted Revenue per Share

Elos Medtech AB (CHIX:ELOSBS) Cyclically Adjusted Revenue per Share : kr64.45 (As of Sep. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Elos Medtech AB Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Elos Medtech AB's adjusted revenue per share for the three months ended in Sep. 2023 was kr31.166. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is kr64.45 for the trailing ten years ended in Sep. 2023.

During the past 12 months, Elos Medtech AB's average Cyclically Adjusted Revenue Growth Rate was 15.00% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 4.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Elos Medtech AB was 4.90% per year. The lowest was 3.80% per year. And the median was 4.35% per year.

As of today (2024-05-25), Elos Medtech AB's current stock price is kr215.00. Elos Medtech AB's Cyclically Adjusted Revenue per Share for the quarter that ended in Sep. 2023 was kr64.45. Elos Medtech AB's Cyclically Adjusted PS Ratio of today is 3.34.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Elos Medtech AB was 4.37. The lowest was 1.60. And the median was 3.64.


Elos Medtech AB Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Elos Medtech AB's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elos Medtech AB Cyclically Adjusted Revenue per Share Chart

Elos Medtech AB Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 94.28 68.55 77.06 78.49 51.79

Elos Medtech AB Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Mar23 Jun23 Sep23
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 56.02 59.11 61.81 63.46 64.45

Competitive Comparison of Elos Medtech AB's Cyclically Adjusted Revenue per Share

For the Medical Instruments & Supplies subindustry, Elos Medtech AB's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Elos Medtech AB's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Elos Medtech AB's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Elos Medtech AB's Cyclically Adjusted PS Ratio falls into.



Elos Medtech AB Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Elos Medtech AB's adjusted Revenue per Share data for the three months ended in Sep. 2023 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Sep. 2023 (Change)*Current CPI (Sep. 2023)
=31.166/130.2235*130.2235
=31.166

Current CPI (Sep. 2023) = 130.2235.

Elos Medtech AB Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201309 12.429 100.544 16.098
201312 14.511 100.541 18.795
201403 13.300 99.788 17.357
201406 15.224 100.432 19.740
201409 12.759 100.161 16.589
201412 15.954 100.225 20.729
201503 15.855 99.950 20.657
201506 20.905 99.995 27.225
201509 18.500 100.228 24.037
201512 20.433 100.276 26.535
201603 21.100 100.751 27.272
201606 22.783 101.019 29.369
201609 19.041 101.138 24.517
201612 20.031 102.022 25.568
201703 23.285 102.022 29.722
201706 25.715 102.752 32.590
201709 21.897 103.279 27.610
201712 22.380 103.793 28.079
201803 25.264 103.962 31.646
201806 20.575 104.875 25.548
201809 19.100 105.679 23.536
201812 20.926 105.912 25.730
201903 23.450 105.886 28.840
201906 22.819 106.742 27.839
201909 19.472 107.214 23.651
201912 19.621 107.766 23.710
202003 19.695 106.563 24.068
202006 14.663 107.498 17.763
202009 18.311 107.635 22.154
202012 19.187 108.296 23.072
202103 21.220 108.360 25.502
202106 22.434 108.928 26.820
202109 23.188 110.338 27.367
202112 22.829 112.486 26.429
202203 24.108 114.825 27.341
202206 28.881 118.384 31.769
202209 28.647 122.296 30.504
202303 33.118 127.042 33.947
202306 33.296 129.407 33.506
202309 31.166 130.224 31.166

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Elos Medtech AB  (CHIX:ELOSBs) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Elos Medtech AB's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=215.00/64.45
=3.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Elos Medtech AB was 4.37. The lowest was 1.60. And the median was 3.64.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Elos Medtech AB Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Elos Medtech AB's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Elos Medtech AB (CHIX:ELOSBS) Business Description

Traded in Other Exchanges
N/A
Address
Torsgatan 5B, Gothenburg, SWE, 411 04
Elos Medtech AB operates in the medical technology business. It develops and produces medical technology products and components. The company operates through three business segments including Dental, Orthopedics, and Life science. Some of its products include Implants, Screws, Plates, Prosthetics, and Drills.

Elos Medtech AB (CHIX:ELOSBS) Headlines

No Headlines